APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine & Radiopharmaceuticals

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Selected research

Market Analysis & Forecast

Global Nuclear Medicine & Radiopharmaceuticals Market Analysis and Forecast 2026-2032

Report ID 17401806021 January 2026199 pages

Choose your research edition.

Industry ResearchNuclear Medicine & Radiopharmaceuticals Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine & Radiopharmaceuticals Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine & Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine & Radiopharmaceuticals Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine & Radiopharmaceuticals Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

This report presents an overview of global market for Nuclear Medicine & Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Nuclear Medicine & Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Nuclear Medicine & Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Medicine & Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nuclear Medicine & Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nuclear Medicine & Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

Nuclear Medicine & Radiopharmaceuticals Segment by Company

China Isotope & Radiation

Dongcheng

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing

Nuclear Medicine & Radiopharmaceuticals Segment by Type

Diagnostic

Therapeutic

Nuclear Medicine & Radiopharmaceuticals Segment by Application

Oncology

Thyroid

Cardiology

Others

Nuclear Medicine & Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine & Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine & Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine & Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nuclear Medicine & Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine & Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostic Major Manufacturers Table 3. Therapeutic Major Manufacturers Table 4. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oncology Major Manufacturers Table 6. Thyroid Major Manufacturers Table 7. Cardiology Major Manufacturers Table 8. Others Major Manufacturers Table 9. Nuclear Medicine & Radiopharmaceuticals Industry Trends Table 10. Nuclear Medicine & Radiopharmaceuticals Industry Drivers Table 11. Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges Table 12. Nuclear Medicine & Radiopharmaceuticals Industry Restraints Table 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 18. Global Nuclear Medicine & Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 20. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2027-2032) & (K Units) Table 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 22. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026) Table 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Nuclear Medicine & Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Nuclear Medicine & Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers, Product Type & Application Table 31. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Nuclear Medicine & Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 38. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 39. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 41. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 42. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 43. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 44. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2026) & (US$/Unit) Table 45. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2027-2032) & (US$/Unit) Table 46. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 50. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 51. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 53. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 54. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 55. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 56. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2027-2032) & (US$/Unit) Table 58. China Isotope & Radiation Company Information Table 59. China Isotope & Radiation Business Overview Table 60. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 62. China Isotope & Radiation Recent Development Table 63. Dongcheng Company Information Table 64. Dongcheng Business Overview Table 65. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 67. Dongcheng Recent Development Table 68. Jaco Company Information Table 69. Jaco Business Overview Table 70. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 72. Jaco Recent Development Table 73. Ciaeriar Company Information Table 74. Ciaeriar Business Overview Table 75. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 77. Ciaeriar Recent Development Table 78. Advanced Molecular-imaging Solution Company Information Table 79. Advanced Molecular-imaging Solution Business Overview Table 80. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 82. Advanced Molecular-imaging Solution Recent Development Table 83. Shanghai Atom Kexing Company Information Table 84. Shanghai Atom Kexing Business Overview Table 85. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 87. Shanghai Atom Kexing Recent Development Table 88. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 91. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 92. North America Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 97. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 98. North America Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 105. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 106. North America Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 109. Canada Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 110. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 111. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 114. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 115. Europe Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 116. Europe Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 117. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 120. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 121. Europe Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 122. Europe Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 123. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 128. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 129. Europe Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 130. Europe Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 131. Germany Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 132. France Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 133. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 134. Italy Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 135. Russia Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 136. Spain Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 139. Sweden Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 140. Poland Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 141. China Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 142. China Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 143. China Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 144. China Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 145. China Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 146. China Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 147. China Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 148. China Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 149. China Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 150. China Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 151. China Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 152. China Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 156. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 157. Asia Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 158. Asia Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 159. Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 162. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 163. Asia Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 164. Asia Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 170. Asia Nuclear Medicine & Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 171. Asia Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 172. Asia Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Japan Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 174. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 175. India Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 176. Australia Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 182. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 183. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Unit) Table 184. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Unit) Table 185. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 188. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 189. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Unit) Table 190. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Unit) Table 191. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 196. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 197. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Unit) Table 198. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 200. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 201. Chile Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 202. Colombia Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 203. Peru Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 205. Israel Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 206. UAE Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 207. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 208. Iran Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 209. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Nuclear Medicine & Radiopharmaceuticals Distributors List Table 213. Nuclear Medicine & Radiopharmaceuticals Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Nuclear Medicine & Radiopharmaceuticals Image Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostic Image Figure 5. Therapeutic Image Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oncology Image Figure 9. Thyroid Image Figure 10. Cardiology Image Figure 11. Others Image Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2021-2032) Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Nuclear Medicine & Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 21. Europe Nuclear Medicine & Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 22. China Nuclear Medicine & Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Nuclear Medicine & Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales YoY (2021-2032) & (K Units) Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 37. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 40. North America Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 41. North America Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 42. North America Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 43. North America Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 44. North America Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 45. North America Nuclear Medicine & Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 46. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 47. Europe Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 48. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 49. Europe Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 50. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 51. Europe Nuclear Medicine & Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 52. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 53. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 54. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 55. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 56. Asia Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 57. Asia Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 58. Asia Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 59. Asia Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 60. Asia Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 61. Asia Nuclear Medicine & Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 62. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 63. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 64. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 65. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 66. SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 67. SAMEA Nuclear Medicine & Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 68. Nuclear Medicine & Radiopharmaceuticals Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Nuclear Medicine & Radiopharmaceuticals Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic
  • Therapeutic
Applications
  • Oncology
  • Thyroid
  • Cardiology
  • Others
Companies covered
  • China Isotope & Radiation
  • Dongcheng
  • Jaco
  • Ciaeriar
  • Advanced Molecular-imaging Solution
  • Shanghai Atom Kexing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nuclear Medicine & Radiopharmaceuticals Market by Type
  3. 1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic
  5. 1.2.3 Therapeutic
  6. 1.3 Nuclear Medicine & Radiopharmaceuticals Market by Application
  7. 1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oncology
  9. 1.3.3 Thyroid
  10. 1.3.4 Cardiology
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nuclear Medicine & Radiopharmaceuticals Market Dynamics
  1. 2.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
  2. 2.2 Nuclear Medicine & Radiopharmaceuticals Industry Drivers
  3. 2.3 Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine & Radiopharmaceuticals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region
  3. 3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2021-2026)
  5. 3.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2027-2032)
  6. 3.2.4 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region
  9. 3.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026)
  11. 3.4.3 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2027-2032)
  12. 3.4.4 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers
  2. 4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers
  6. 4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nuclear Medicine & Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nuclear Medicine & Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers, Product Type & Application
  13. 4.7 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nuclear Medicine & Radiopharmaceuticals Market CR5 and HHI
  16. 4.8.2 2025 Nuclear Medicine & Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
5 Nuclear Medicine & Radiopharmaceuticals Market by Type
  1. 5.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type
  2. 5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type
  6. 5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type
6 Nuclear Medicine & Radiopharmaceuticals Market by Application
  1. 6.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application
  2. 6.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application
  6. 6.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application
7 Company Profiles
  1. 7.1 China Isotope & Radiation
  2. 7.1.1 China Isotope & Radiation Company Information
  3. 7.1.2 China Isotope & Radiation Business Overview
  4. 7.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  6. 7.1.5 China Isotope & Radiation Recent Developments
  7. 7.2 Dongcheng
  8. 7.2.1 Dongcheng Company Information
  9. 7.2.2 Dongcheng Business Overview
  10. 7.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  12. 7.2.5 Dongcheng Recent Developments
  13. 7.3 Jaco
  14. 7.3.1 Jaco Company Information
  15. 7.3.2 Jaco Business Overview
  16. 7.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  18. 7.3.5 Jaco Recent Developments
  19. 7.4 Ciaeriar
  20. 7.4.1 Ciaeriar Company Information
  21. 7.4.2 Ciaeriar Business Overview
  22. 7.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  24. 7.4.5 Ciaeriar Recent Developments
  25. 7.5 Advanced Molecular-imaging Solution
  26. 7.5.1 Advanced Molecular-imaging Solution Company Information
  27. 7.5.2 Advanced Molecular-imaging Solution Business Overview
  28. 7.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  30. 7.5.5 Advanced Molecular-imaging Solution Recent Developments
  31. 7.6 Shanghai Atom Kexing
  32. 7.6.1 Shanghai Atom Kexing Company Information
  33. 7.6.2 Shanghai Atom Kexing Business Overview
  34. 7.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  36. 7.6.5 Shanghai Atom Kexing Recent Developments
8 North America
  1. 8.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Type
  2. 8.1.1 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 8.1.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032)
  4. 8.1.3 North America Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2032)
  5. 8.2 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Application
  6. 8.2.1 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 8.2.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032)
  8. 8.2.3 North America Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2032)
  9. 8.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  10. 8.3.1 North America Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nuclear Medicine & Radiopharmaceuticals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Type
  2. 9.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032)
  4. 9.1.3 Europe Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2032)
  5. 9.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Application
  6. 9.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032)
  8. 9.2.3 Europe Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2032)
  9. 9.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  10. 9.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nuclear Medicine & Radiopharmaceuticals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nuclear Medicine & Radiopharmaceuticals Market Size by Type
  2. 10.1.1 China Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 10.1.2 China Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032)
  4. 10.1.3 China Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2032)
  5. 10.2 China Nuclear Medicine & Radiopharmaceuticals Market Size by Application
  6. 10.2.1 China Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 10.2.2 China Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032)
  8. 10.2.3 China Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nuclear Medicine & Radiopharmaceuticals Market Size by Type
  2. 11.1.1 Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032)
  4. 11.1.3 Asia Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2032)
  5. 11.2 Asia Nuclear Medicine & Radiopharmaceuticals Market Size by Application
  6. 11.2.1 Asia Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032)
  8. 11.2.3 Asia Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2032)
  9. 11.3 Asia Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  10. 11.3.1 Asia Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nuclear Medicine & Radiopharmaceuticals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nuclear Medicine & Radiopharmaceuticals Market Size by Type
  2. 12.1.1 SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2032)
  5. 12.2 SAMEA Nuclear Medicine & Radiopharmaceuticals Market Size by Application
  6. 12.2.1 SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2032)
  9. 12.3 SAMEA Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  10. 12.3.1 SAMEA Nuclear Medicine & Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nuclear Medicine & Radiopharmaceuticals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nuclear Medicine & Radiopharmaceuticals Value Chain Analysis
  2. 13.1.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process
  6. 13.2 Nuclear Medicine & Radiopharmaceuticals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nuclear Medicine & Radiopharmaceuticals Distributors
  9. 13.2.3 Nuclear Medicine & Radiopharmaceuticals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst